Financial News
Latest News about MRK
Recent news which mentions MRK
P/E Ratio Insights for Merck & Co
January 05, 2024
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 04, 2024
From Benzinga
McDonald's Revenues Expected To Increase, Plus Merck And More On CNBC's 'Final Trades'
January 04, 2024
From Benzinga
2024 And Beyond – Exploring Six Investment Megatrends With Tema ETFs
January 04, 2024
From Benzinga
From Benzinga
Revenge of the Boring Stocks! Dividends Are Sexy Again.
January 03, 2024
From InvestorPlace
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 02, 2024
From Benzinga
There Are Only 5 Dow Stocks I Wouldn't Buy in 2024
December 29, 2023
From Motley Fool
Moderna Stock Is Climbing Thanks to Merck, But Is It Still a Buy?
December 29, 2023
From Motley Fool
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
December 29, 2023
From Benzinga
Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024
December 28, 2023
From Benzinga
January Effect: 3 Under-the-Radar Stocks Poised for a New Year Jump
December 24, 2023
From InvestorPlace
7 Small-Cap Stocks That Wall Street Loves for Good Reason
December 22, 2023
Tags
NASDAQ:GPCR,NASDAQ:ALXO,NYSE:MRK,NYSE:LLY,NASDAQ:SKWD,NASDAQ:LFMD,NASDAQ:VSEC,NYSE:ASM,NASDAQ:PETQ
MRK
Market News
From InvestorPlace
7 Best Dow Jones Stocks to Buy for Conservative Investors
December 21, 2023
From InvestorPlace
From Benzinga
Better Dividend Stock: Bristol Myers Squibb or Merck?
December 19, 2023
From Motley Fool
Jim Cramer Slams FTC Chair Lina Khan's Policies For Hampering Investor Returns: 'One-Woman Wrecking Crew For Your Stock Portfolio'
December 18, 2023
From Benzinga
From Motley Fool
From Motley Fool
Contaminated Vaccines: FDA Reportedly Finds Cleaning And Expiry Lapses At Moderna's Massachusetts Facility
December 16, 2023
From Benzinga
What's Going On With C4 Therapeutics Stock?
December 15, 2023
From Benzinga
FDA Approves Merck's Drug Belzutifan For Type Of Advanced Kidney Cancer In Pretreated Cancer Patients
December 15, 2023
From Benzinga
MRNA Stock Surges as Moderna Teams Up With Merck to Fight Cancer
December 14, 2023
From InvestorPlace
Moderna CEO Highlights Promising Cancer Vaccine Data: 'Think About The Number Of Lives That Can Be Impacted'
December 14, 2023
From Benzinga
Moderna’s stock boosted by positive data from trial of melanoma treatment combined with Merck’s Keytruda
December 14, 2023
From MarketWatch
Why Is Moderna (MRNA) Stock Up 11% Today?
December 14, 2023
From InvestorPlace
Moderna Stock Is Soaring Today - Here's Why
December 14, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
